Skip to main content
TipRanks
Go Ultimate75% OFF

CASI Pharmaceuticals (ENM) Q4 2022 Earnings Report

0 Followers

CH:ENM Q4 2022 EPS Results

Actual EPS
-CHF 0.38
Consensus EPS
-CHF 0.54
Beat/Miss
Beat by +CHF 0.16
One Year Ago EPS
-CHF 0.50

CH:ENM Q4 2022 Revenue Results

Actual Revenue
CHF 7.01M
Expected Revenue
CHF 7.65M
Beat/Miss
Missed by -CHF 632.79K
YoY Revenue Growth
-8.48%

Earnings Announcement Details

Quarter
Q4 2022
Date
04/26/2023
Time
TBA
Conference Call
Wednesday, April 26, 2023
CH:ENM Upcoming Earnings

CASI Pharmaceuticals's next earnings date is estimated for May 20, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:ENM Earnings History

CH:ENM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 20, 20272027 (Q1)―-―――
Nov 13, 20262026 (Q3)―--0.57―
Aug 14, 20262026 (Q2)―-0.82-0.72-13.37% (-0.10)
May 14, 20262026 (Q1)―--0.58―
Apr 29, 20262025 (Q4)―--0.58―
Nov 14, 20252025 (Q3)-0.34-0.57-0.46-23.64% (-0.11)
Aug 29, 20252025 (Q2)-0.39-0.72-0.44-65.38% (-0.29)
May 16, 20252025 (Q1)―-0.58-0.62.82% (+0.02)
Mar 31, 20252024 (Q4)-0.51-0.58-0.62.82% (+0.02)
Nov 15, 20242024 (Q3)-0.52-0.46-0.29-57.14% (-0.17)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed